Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0

Frontiers in Immunology- Switzerland

doi 10.3389/fimmu.2018.01621

Full Text

Abstract

Available in

Date

Authors

Publisher

Frontiers Media SA

Related search

Editorial: Reverse Vaccinology

Frontiers in Immunology
AllergyImmunology
2019English

Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges

Frontiers in Immunology
AllergyImmunology
2018English

Invasive Meningococcal Disease in Childhood

Pediatrics in Review
MedicineChild HealthPediatricsPerinatology
2011English

Vaccines, Reverse Vaccinology, and Bacterial Pathogenesis

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Invasive Meningococcal Disease in Adolescents and Young Adults

JAMA - Journal of the American Medical Association
Medicine
2001English

Autoantigen Cross-Reactive Environmental Antigen Can Trigger Multiple Sclerosis-Like Disease

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology

Frontiers in Immunology
AllergyImmunology
2017English

Can Kawasaki Disease Be Managed?

Permanente journal,The
Medicine
2012English

Pin23 - Clinical and Economic Burden of Invasive Meningococcal Disease in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy